Chest Trauma Scoring Systems as Predictors of Morbidity and Mortality in Iraq (CTS)

March 16, 2025 updated by: Abdul-Ilah R. Khamis, Al-Nahrain University

Validation of Chest Trauma Scoring Systems in Predicting Blunt Chest Injury Outcomes in Iraq: A Prospective Study

This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:

How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?

Participants will:

Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.

Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Chest trauma is a major cause of morbidity and mortality, often resulting from motor vehicle accidents, falls, or physical assaults. It can lead to serious complications such as pulmonary contusions, rib fractures, and damage to thoracic organs. The Chest Trauma Score (CTS) helps assess injury severity by considering factors like age, number of rib fractures, and pulmonary contusion severity. Higher CTS values are associated with worse outcomes, such as prolonged mechanical ventilation and higher mortality rates. Early identification using this scoring system improves clinical decision-making and outcomes.

Despite the global utility of trauma scoring systems, there is limited research on their application in developing countries like Iraq, where trauma care is often constrained by limited resources and inconsistent protocols. In Iraq, blunt chest trauma is a prevalent issue due to frequent road traffic accidents and other causes. However, a lack of locally validated tools such as CTS hinders the ability of healthcare providers to assess injury severity accurately and predict outcomes.

This study aims to evaluate the effectiveness of the Chest Trauma Score in predicting morbidity and mortality among patients with blunt chest trauma in Iraq. By addressing this research gap, the findings will contribute to improving trauma care protocols, informing policy decisions, and enhancing the overall healthcare system's capacity to manage chest trauma effectively.

Study Type

Observational

Enrollment (Estimated)

190

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Iraq
      • Baghdad, Iraq
        • College of Medicine - Al-Nahrain University
        • Principal Investigator:
          • Abdul-Ilah R. Khamis
        • Sub-Investigator:
          • Sanarya N Abd-Al-Taj, Student
        • Contact:
        • Sub-Investigator:
          • Murtaja Satea Shafeea, MD
        • Sub-Investigator:
          • Mesan A. Hijazy, Student
        • Sub-Investigator:
          • Mustafa H. Alsaadi, Student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of adult patients aged 18 years and older presenting to the emergency department with blunt chest trauma. Participants will be assessed using the Chest Trauma Score (CTS) to predict morbidity and mortality, and data on demographics, injury mechanisms, and clinical outcomes will be collected. The study aims to include a diverse sample from varying age groups and both genders to evaluate the score's performance across different subgroups.

Description

Inclusion Criteria:

  • Patients diagnosed with blunt chest trauma.
  • Patients presenting to the emergency department within 4 hours.
  • Patients (or their legal representatives) must provide informed consent to participate in the study.
  • Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).

Exclusion Criteria:

  • Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
  • Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
  • Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
  • Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
  • Patients who refuse consent or do not agree to the use of their data for research purposes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In hospital mortality
Time Frame: In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30
Mortality (death) during hospitalization.
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30
Accuracy Assessment of the Chest Trauma Score (CTS)
Time Frame: the first 4 hours after ER admission
The total score ranges from 2 to 12, with higher scores indicating worse outcomes.
the first 4 hours after ER admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Requiring ICU Admission
Time Frame: Up to discharge, an average of 10 days
The requirement for admission to the intensive care unit (ICU) is determined by the presence of severe clinical deterioration, significant complications, or the need for advanced monitoring and life-support measures.
Up to discharge, an average of 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Nahrain University

Investigators

  • Study Director: Yaser aamer Eisa Alhaibi, Assistant professor, College Of Medicine - Nahrain University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2025

Primary Completion (Estimated)

June 10, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

December 12, 2024

First Submitted That Met QC Criteria

December 12, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 16, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UNCOMIRB20241212A
  • 013 (Nahrain Medical Research Collective (NMRC))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chest Injury Trauma Blunt

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe